advertisement
Żarnowski T 33
Showing records 1 to 25 | Display all abstracts from Żarnowski T80768 Phacotrabeculectomy using collagen matrix implant (Ologen ) versus mitomycin C: a prospective randomized controlled trial
Wlaź A
Acta Ophthalmologica 2019; 97: e817-e826
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Aptel F
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Aptel F
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Pfeiffer N
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Pfeiffer N
Journal of Glaucoma 2019; 28: 498-506
80768 Phacotrabeculectomy using collagen matrix implant (Ologen ) versus mitomycin C: a prospective randomized controlled trial
Wilkos-Kuc A
Acta Ophthalmologica 2019; 97: e817-e826
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Schmickler S
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Schmickler S
Journal of Glaucoma 2019; 28: 498-506
80768 Phacotrabeculectomy using collagen matrix implant (Ologen ) versus mitomycin C: a prospective randomized controlled trial
Rozegnał-Madej A; Żarnowski T
Acta Ophthalmologica 2019; 97: e817-e826
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Clarke J
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Clarke J; Lavín-Dapena C
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C; Moreno-Montañés J
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Moreno-Montañés J
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Żarnowski T
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Żarnowski T
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Csutak A
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Csutak A
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Volksone L
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Volksone L; Astakhov YS
Journal of Glaucoma 2019; 28: 498-506
